Literature DB >> 10846064

Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.

M Tritel1, M D Resh.   

Abstract

The assembly and budding of lentiviruses, such as human immunodeficiency virus type 1 (HIV-1), are mediated by the Gag protein precursor, but the molecular details of these processes remain poorly defined. In this study, we have combined pulse-chase techniques with density gradient centrifugation to identify, isolate, and characterize sequential kinetic intermediates in the lentivirus assembly process. We show that newly synthesized HIV-1 Gag rapidly forms cytoplasmic protein complexes that are resistant to detergent treatment, sensitive to protease digestion, and degraded intracellularly. A subpopulation of newly synthesized Gag binds membranes within 5 to 10 min and over several hours assembles into membrane-bound complexes of increasing size and/or density that can be resolved on Optiprep density gradients. These complexes likely represent assembly intermediates because they are not observed with assembly-defective Gag mutants and can be chased into extracellular viruslike particles. At steady state, nearly all of the Gag is present as membrane-bound complexes in various stages of assembly. The identification of sequential assembly intermediates provides the first demonstration that HIV-1 particle assembly proceeds via an ordered process. Assembly intermediates should serve as attractive targets for the design of antiviral agents that interfere with the process of particle production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846064      PMCID: PMC112079          DOI: 10.1128/jvi.74.13.5845-5855.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  In vitro assembly of human immunodeficiency virus type 1 Gag protein.

Authors:  Y Morikawa; T Goto; K Sano
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

2.  Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

Authors:  S Schwartz; M Campbell; G Nasioulas; J Harrison; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

Authors:  D Gheysen; E Jacobs; F de Foresta; C Thiriart; M Francotte; D Thines; M De Wilde
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

8.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

9.  Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.

Authors:  D Picard; K R Yamamoto
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Highly specific antibody to Rous sarcoma virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules.

Authors:  M D Resh; R L Erikson
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

View more
  67 in total

1.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.

Authors:  Rabih Halwani; Ahmad Khorchid; Shan Cen; Lawrence Kleiman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  A myristoyl switch regulates membrane binding of HIV-1 Gag.

Authors:  Marilyn D Resh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-05       Impact factor: 11.205

Review 8.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

9.  Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy.

Authors:  Daniel R Larson; Yu May Ma; Volker M Vogt; Watt W Webb
Journal:  J Cell Biol       Date:  2003-09-29       Impact factor: 10.539

10.  Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding.

Authors:  O Wolf Lindwasser; Marilyn D Resh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.